mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-10 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
5e-10 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-10 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |